Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib Plus Fulvestrant in ER+/HER2- Metastatic Breast Cancer
NCT02536742Phase 2Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Aug 2016
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by ETOP IBCSG Partners Foundation. Started Aug 2016; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02536742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536742.